B

Brainstorm Cell Therapeutics
D

BCLI

2.26000
USD
0.23
(11.33%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-1
Market Cap
12,889,743
OverviewSignalsIdeasNews
Related Instruments
    A
    APLS
    0.090
    (0.27%)
    33.220 USD
    A
    ASND
    -1.560
    (-1.13%)
    136.110 USD
    A
    ATHA
    0.03110
    (5.76%)
    0.57130 USD
    M
    MBIO
    0.00590
    (3.49%)
    0.17490 USD
    M
    MDB
    0.820
    (0.33%)
    245.820 USD
    Q
    QURE
    1.550
    (10.00%)
    17.050 USD
    R
    RYTM
    0.550
    (0.99%)
    56.070 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    More
News

Title: Brainstorm Cell Therapeutics

Sector: Healthcare
Industry: Biotechnology
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.